Zimmer Biomet Q1 FY26: where the revenue came from and where it went
The whole income statement of Zimmer Biomet for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 1, 2026
Revenue$2.09B
+9% year over year
Gross profit$1.51B
72% margin
Operating profit$0.37B
18% margin
Net profit$0.24B
11% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.09 | 100% | +9% |
| Knees | 0.83 | 40% | +5% |
| SET | 0.56 | 27% | +19% |
| Hips | 0.52 | 25% | +6% |
| Technology & data bone | 0.17 | 8% | +15% |
| Cost of revenue | −0.58 | 28% | |
| Gross profit | 1.51 | 72% margin | +1pp |
| SG&A | −0.85 | 40% | +1pp |
| Other | −0.29 | 14% | |
| Operating profit | 0.37 | 18% margin | +3pp |
| Interest & other costs | −0.07 | ||
| Tax | −0.06 | ||
| Net profit | 0.24 | 11% margin | +2pp |
136 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest